lobbying_activities: 1806985
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1806985 | c3cf1e74-ef9f-49c6-9e8d-4803ea2edc9a | Q1 | STANTON PARK GROUP | 83717 | MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY) | 2016 | first_quarter | MMM | Medicare, oncology, radiation and imaging reimbursement issues; Medicare physician payments; application of the sequester to cancer drug reimbursement; prompt pay discount; Oncology payment disparities in Medicare HR 2, Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) H.R.2895, the Medicare Patient Access to Cancer Treatment Act of 2015 HR 6, the 21st Century Cures Act Part B Drug Reimbursement | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2016-04-13T17:40:11.483000-04:00 |